Brief: Q Biomed Announces Legal Settlement And Acquisition Of FDA Approved Non-Opioid Metastatic Cancer Pain Drug
02/10/2019 16:45
Oct 2 (Reuters) - Q BioMed Inc QBIO.PK :
* Q BIOMED ANNOUNCES LEGAL SETTLEMENT AND ACQUISITION OF FDA
APPROVED NON-OPIOID METASTATIC CANCER PAIN DRUG
* Q BIOMED - ENTERED SETTLEMENT AGREEMENT WITH BIONUCLEONICS
TO
COMPLETE OUTRIGHT ACQUISITION OF NON-OPIOID CANCER BONE PAIN
DRUG STRONTIUM-89 CHLORIDE USP
* Q BIOMED INC - WILL ASSUME IMMEDIATE OWNERSHIP OF DRUG,
INCLUDING ANDA UNDER A MUTUALLY FAVORABLE GLOBAL ROYALTY
AGREEMENT
Source text for Eikon: ID:nPn4Jx4g4a
Further company coverage: QBIO.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Q BioMed
See all newsBrief: Q Biomed Inc. Chemotherapeutic Uttroside B, Receives Patent From United States Patent Office And Notice Of Allowance For Europe
Brief: Q Biomed Provides Shareholder Update
Brief: Q Biomed Announces Publication Of Research Showing Augmented Efficacy Of Its Drug Candidate Uttroside-B Against Liver Cancer
Brief: Q BioMed Inc Updates On COVID-19 Therapeutic Development And Clinical Trials
Brief: Q Biomed To Scale Up Production Of Uttroside-B